keyword
Keywords carbon monoxide diffusing capa...

carbon monoxide diffusing capacity of the lungs

https://read.qxmd.com/read/38652535/characteristics-and-determinants-of-pulmonary-long-covid
#1
JOURNAL ARTICLE
Michael John Patton, Donald Benson, Sarah W Robison, Dhaval Raval, Morgan L Locy, Kinner Patel, Scott Grumley, Emily B Levitan, Peter Morris, Matthew Might, Amit Gaggar, Nathaniel Erdmann
BACKGROUNDPersistent cough and dyspnea are prominent features of post-acute sequelae of SARS-CoV-2 (also termed 'Long COVID'); however, physiologic measures and clinical features associated with these pulmonary symptoms remain poorly defined. Using longitudinal pulmonary function testing (PFTs) and CT imaging, this study aimed to identify the characteristics and determinants of pulmonary Long COVID.METHODSThis single-center retrospective study included 1,097 patients with clinically defined Long COVID characterized by persistent pulmonary symptoms (dyspnea, cough, and chest discomfort) lasting for ≥1 month after resolution of primary COVID infection...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38641768/a-first-look-at-the-reliability-validity-and-responsiveness-of-l-pf-35-dyspnea-domain-scores-in-fibrotic-hypersensitivity-pneumonitis
#2
JOURNAL ARTICLE
Jeffrey J Swigris, Kerri Aronson, Evans R Fernández Pérez
BACKGROUND: Dyspnea impairs quality of life (QOL) in patients with fibrotic hypersensitivity pneumonitis (FHP). The Living with Pulmonary Fibrosis questionnaire (L-PF) assesses symptoms, their impacts and PF-related QOL in patients with any form of PF. Its scores have not undergone validation analyses in an FHP cohort. METHODS: We used data from the Pirfenidone in FHP trial to examine reliability, validity and responsiveness of the L-PF-35 Dyspnea domain score (Dyspnea) and to estimate its meaningful within-patient change (MWPC) threshold for worsening...
April 19, 2024: BMC Pulmonary Medicine
https://read.qxmd.com/read/38640289/a-retrospective-study-of-combination-therapy-with-glucocorticoids-and-pirfenidone-for-pd-1-inhibitor-related-immune-pneumonitis
#3
JOURNAL ARTICLE
Yong Li, Huiqin Huang, Xiangli Ye, Bangwei Zeng, Feijian Huang, Limin Chen
Immune checkpoint inhibitor pneumonitis (ICIP) is thought to be a self-limiting disease; however, an effective treatment option does not currently exist. This study aimed to determine the clinical efficacy of combination therapy with glucocorticoids and pirfenidone for ICIP related to programmed cell death protein-1 (PD-1) inhibitors. We conducted a retrospective analysis of 45 patients with advanced non-small cell lung cancer who developed ICIP following PD-1 inhibitor and albumin-bound paclitaxel or carboplatin treatment at our hospital...
April 19, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38637891/treatment-of-covid-19-associated-ards-with-umbilical-cord-derived-mesenchymal-stromal-cells-in-the-stroma-cov-2-multicenter-randomized-double-blind-trial-long-term-safety-respiratory-function-and-quality-of-life
#4
JOURNAL ARTICLE
Alexandre Sitbon, Caroline Hauw-Berlemont, Miryam Mebarki, Nicholas Heming, Julien Mayaux, Jean-Luc Diehl, Alexandre Demoule, Djillali Annane, Clémence Marois, Sophie Demeret, Emmanuel Weiss, Guillaume Voiriot, Muriel Fartoukh, Jean-Michel Constantin, Bruno Mégarbane, Gaëtan Plantefève, Hélène Boucher-Pillet, Guillaume Churlaud, Audrey Cras, Camille Maheux, Chloé Pezzana, Mamadou Hassimiou Diallo, Said Lebbah, Jacques Ropers, Joe-Elie Salem, Christian Straus, Philippe Menasché, Jérôme Larghero, Antoine Monsel
BACKGROUND: The STROMA-CoV-2 study was a French phase 2b, multicenter, double-blind, randomized, placebo-controlled clinical trial that did not identify a significant efficacy of umbilical cord-derived mesenchymal stromal cells in patients with SARS-CoV-2-induced acute respiratory distress syndrome. Safety on day 28 was found to be good. The aim of our extended study was to assess the 6- and 12-month safety of UC-MSCs administration in the STROMA-CoV-2 cohort. METHODS: A detailed multi-domain assessment was conducted at 6 and 12 months following hospital discharge focusing on adverse events, lung computed tomography-scan, pulmonary and muscular functional status, and quality of life in the STROMA-CoV-2 cohort including SARS-CoV-2-related early (< 96 h) mild-to-severe acute respiratory distress syndrome...
April 19, 2024: Stem Cell Research & Therapy
https://read.qxmd.com/read/38635535/twenty-four-week-taichi-training-improves-pulmonary-diffusion-capacity-and-glycemic-control-in-patients-with-type-2-diabetes-mellitus
#5
JOURNAL ARTICLE
Xiaoli Liu, Huan Zhu, Yong Peng, Yaofeng Liu, Xiangrong Shi
This study evaluated the effect of 24-week Taichi training and Taichi plus resistance band training on pulmonary diffusion capacity and glycemic control in patients with Type 2 diabetes mellitus (T2DM). Forty-eight patients with T2DM were randomly divided into three groups: Group A-Taichi training: practiced Taichi 60 min/day, 6 days/week for 24 weeks; Group B-Taichi plus resistance band training: practiced 60-min Taichi 4 days/week plus 60-min resistance band training 2 days/week for 24 weeks; and Group C-controls: maintaining their daily lifestyles...
2024: PloS One
https://read.qxmd.com/read/38633577/fapi-pet-ct-for-assessment-and-visualisation-of-active-myositis-related-interstitial-lung-disease-a-prospective-observational-pilot-study
#6
JOURNAL ARTICLE
Kastriot Kastrati, Thomas S Nakuz, Oana C Kulterer, Irina Geßl, Elisabeth Simader, Daniel Mrak, Michael Bonelli, Hans Peter Kiener, Florian Prayer, Helmut Prosch, Daniel Aletaha, Werner Langsteger, Tatjana Traub-Weidinger, Stephan Blüml, Helga Lechner-Radner, Marcus Hacker, Peter Mandl
BACKGROUND: Interstitial lung disease (ILD) is a common manifestation of idiopathic inflammatory myopathies (IIM) and a substantial contributor to hospitalisation, increased morbidity, and mortality. In-vivo evidence of ongoing tissue remodelling in IIM-ILD is scarce. We aimed to evaluate fibroblast activation in lungs of IIM-patients and control individuals using ⁶⁸Ga-labelled inhibitor of Fibroblast-Activation-Protein (FAPi) based positronic emission tomography and computed tomography imaging (PET/CT)...
June 2024: EClinicalMedicine
https://read.qxmd.com/read/38633574/reduced-lung-function-during-childhood-in-identical-twins-with-discordant-fetal-growth-a-cohort-study
#7
JOURNAL ARTICLE
Jip A Spekman, Joël Israëls, Ilja de Vreede, Mady Los, Miranda J J Geelhoed, Erik W van Zwet, Monique C Haak, Arno A W Roest, Jeanine M M van Klink, Enrico Lopriore, Sophie G Groene
BACKGROUND: Fetal growth restriction (FGR) can negatively affect lung development, leading to increased respiratory morbidity and reduced lung function later in life. Studies regarding the impact of FGR on lung function in singletons are influenced by genetic, obstetric, and maternal factors. To overcome these confounding factors, we aim to investigate lung function in identical twins with selective FGR (sFGR). METHODS: Lung function assessments were performed in identical twins with sFGR born in our centre between March 1, 2002, and December 31, 2017, aged between 5 and 17 years...
June 2024: EClinicalMedicine
https://read.qxmd.com/read/38633311/residual-radiological-opacities-correlate-with-disease-outcomes-in-icu-treated-covid-19
#8
JOURNAL ARTICLE
Mikael Björnson, Ann Mari Svensson, Cecilia He, Magnus Sköld, Sven Nyrén, Malin Nygren-Bonnier, Judith Bruchfeld, Michael Runold, Francesca Campoccia Jalde, Anna Kistner
BACKGROUND: Few studies consider both radiological and functional outcomes in COVID-19 survivors treated in the intensive care unit (ICU). We investigated clinical findings and pulmonary abnormalities on chest computed tomography (CT) and compared outcomes of severe versus mild-moderate acute respiratory distress syndrome (ARDS) on long-term follow-up. METHODS: This longitudinal cohort study included 118 COVID-19 patients (median age, 58 years; 79% men). Thoracic CT scans were performed 4, 10, and 22 months after hospital discharge...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38627696/decreased-serpin-c1-in-extracellular-vesicles-predicts-response-to-methotrexate-treatment-in-patients-with-pulmonary-sarcoidosis
#9
JOURNAL ARTICLE
Raisa Kraaijvanger, Montse Janssen Bonás, Jan C Grutters, Ioanna Paspali, Marcel Veltkamp, Dominique P V de Kleijn, Coline H M van Moorsel
BACKGROUND: Sarcoidosis is a systemic granulomatous disease of unknown etiology primarily affecting the lungs. Treatment is needed when disease symptoms worsen and organ function deteriorates. In pulmonary sarcoidosis, prednisone and methotrexate (MTX) are the most common anti-inflammatory therapies. However, there is large inter-patient variability in response to treatment, and predictive response markers are currently lacking. OBJECTIVE: In this study, we investigated the predictive potential of biomarkers in extracellular vesicles (EVs) isolated from biobanked serum of patients with pulmonary sarcoidosis stored prior to start of therapy...
April 16, 2024: Respiratory Research
https://read.qxmd.com/read/38623400/lung-outcomes-and-related-risk-factors-in-patients-after-sars-cov-2-infection-a-hospitalised-single-centre-cohort-from%C3%A2-johannesburg-south-africa
#10
JOURNAL ARTICLE
Nicole Audrey Glover, Olena Ivanova, Farzana Sathar, Friedrich Riess, Rekha Rao Shambhu, Anna-Maria Mekota, Lindsay Zurba, Colin Menezes, Sarah Alexandra van Blydenstein, Ismail Kalla, Michael Hoelscher, Elmar Saathoff, Salome Charalambous, Andrea Rachow
BACKGROUND: Sequelae post-SARS-CoV-2 infection, including lung and functional impairment, pose a significant challenge post-recovery. We explored the burden and risk factors for post-COVID-19 sequelae in an African population with prevalent comorbidities including tuberculosis (TB) and HIV. METHODS: We conducted an observational cohort study on hospitalised adults with confirmed SARS-CoV-2 infection from 20 March to 06 October 2021 at Chris Hani Baragwanath Academic Hospital, South Africa...
May 2024: EClinicalMedicine
https://read.qxmd.com/read/38619119/serum-levels-of-aggf1-potential-association-with-cutaneous-and-cardiopulmonary-involvements-in-systemic-sclerosis
#11
JOURNAL ARTICLE
Takuya Takahashi, Takehiro Takahashi, Tetsuya Ikawa, Hitoshi Terui, Toshiya Takahashi, Yuichiro Segawa, Hayakazu Sumida, Ayumi Yoshizaki, Shinichi Sato, Yoshihide Asano
Systemic sclerosis (SSc) is an autoimmune disease characterized by vasculopathy, aberrant immune activation, and extensive tissue fibrosis of the skin and internal organs. Because of the complicated nature of its pathogenesis, the underlying mechanisms of SSc remain incompletely understood. Angiogenic factor with a G-patch domain and a Forkhead-associated domain 1 (AGGF1) is a critical factor in angiogenesis expressed on vascular endothelial cells, associated with inflammatory and fibrotic responses. To elucidate the possible implication of AGGF1 in SSc pathogenesis, we investigated the association between serum AGGF1 levels and clinical manifestations in SSc patients...
April 15, 2024: Journal of Dermatology
https://read.qxmd.com/read/38617895/analysis-of-a-serious-adverse-reaction-of-pulmonary-fibrosis-caused-by-dronedarone
#12
Yuyan Chen, Zhendong Fu, Xue Wen, Mingxia Zhang, Qiong Min, Peng Wang, Jin Zhang, Jun Ren, Wenbin Li, Rong Wang
OBJECTIVE: This study aims to analyze a severe adverse reaction of pulmonary fibrosis induced by dronedarone hydrochloride tablets, and to provide a reference for clinical rational medication through drug precautions. METHODS: A case of pulmonary fibrosis induced by dronedarone hydrochloride tablets, along with related literature was retrospectively analyzed. RESULTS: Patients over 65 years old with a history of exposure to amiodarone may increase the incidence of pulmonary toxicity induced by dronedarone, and dronedarone should not be selected as a substitute treatment drug for patients with amiodarone-induced pulmonary toxicity...
2024: Current Therapeutic Research, Clinical and Experimental
https://read.qxmd.com/read/38608658/clinical-course-of-mild-to-moderate-idiopathic-pulmonary-fibrosis-during-therapy-with-pirfenidone-results-of-the-non-interventional-study-aerplus
#13
Jens Schreiber, Wolfgang Schütte, Wolfgang Koerber, Bernd Seese, Dirk Koschel, Kathrin Neuland, Christian Grohé
INTRODUCTION: Pirfenidone was the first anti-fibrotic drug approved in Europe in 2011 for the treatment of mild-to-moderate idiopathic pulmonary fibrosis. OBJECTIVES: To investigate the clinical course of mild-to-moderate idiopathic pulmonary fibrosis in pirfenidone-treated patients in a real-world setting. METHODS: The non-interventional study was conducted at 18 sites in Germany from 6/2014-12/2016. Adult patients with mild-to-moderate idiopathic pulmonary fibrosis were treated with pirfenidone (escalated from 3×1 to 3×3 capsules of 267 mg/day within 3 weeks) for 12 months...
April 2024: Pneumologie
https://read.qxmd.com/read/38598441/significance-of-preoperative-exercise-oxygen-desaturation-in-lung-cancer-with-interstitial-lung-disease
#14
JOURNAL ARTICLE
Takuya Ueda, Kazuya Takamochi, Mariko Fukui, Tomohiro Ichikawa, Aritoshi Hattori, Takeshi Matsunaga, Shiaki Oh, Hisashi Tomita, Kenji Suzuki
OBJECTIVES: Evaluating the diffusing capacity for carbon monoxide (DLco) is crucial for patients with lung cancer and interstitial lung disease. However, the clinical significance of assessing exercise oxygen desaturation (EOD) remains unclear. METHODS: We retrospectively analyzed 186 consecutive patients with interstitial lung disease who underwent lobectomy for non-small cell lung cancer. EOD was assessed using two-flight test (TFT), with TFT positivity defined as ≥ 5% SpO2 reduction...
April 10, 2024: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/38597721/sleep-and-circadian-health-of-critical-survivors-a-12-month-follow-up-study
#15
JOURNAL ARTICLE
Mario Henríquez-Beltrán, Rafaela Vaca, Iván D Benítez, Jessica González, Sally Santisteve, Maria Aguilà, Olga Minguez, Anna Moncusí-Moix, Clara Gort-Paniello, Gerard Torres, Gonzalo Labarca, Jesús Caballero, Carme Barberà, Antoni Torres, David de Gonzalo-Calvo, Ferran Barbé, Adriano D S Targa
OBJECTIVES: To investigate the sleep and circadian health of critical survivors 12 months after hospital discharge and to evaluate a possible effect of the severity of the disease within this context. DESIGN: Observational, prospective study. SETTING: Single-center study. PATIENTS: Two hundred sixty patients admitted to the ICU due to severe acute respiratory syndrome coronavirus 2 infection. INTERVENTIONS: None...
April 10, 2024: Critical Care Medicine
https://read.qxmd.com/read/38595212/effect-of-ultra-marathon-trail-running-at-sea-level-and-altitude-on-alveolar-capillary-function-and-lung-diffusion
#16
JOURNAL ARTICLE
Glenn M Stewart, Caitlin C Fermoyle, Courtney M Wheatley-Guy, Paul Robach, Nicholas B Tiller, Bryan J Taylor, Briana Ziegler, Jesse Schwartz, Alice Gavet, Loïc Chabridon, Robert W Murdock, Keren Constantini, Bruce D Johnson
INTRODUCTION: Endurance exercise at altitude can increase cardiac output and pulmonary vascular pressure to levels that may exceed the stress-tolerability of the alveolar-capillary unit. This study examined the effect of ultra-marathon trail racing at different altitudes (ranging from <1000 m to between 1500 - 2700 m) on alveolar-capillary recruitment and lung diffusion. METHODS: Cardiac and lung function were examined before and after an ultra-marathon in 67 runners (age:41 ± 9y, BMI:23 ± 2 kg/m2, 10 females), and following 12-24 h of recovery in a subset (n = 27)...
April 8, 2024: Medicine and Science in Sports and Exercise
https://read.qxmd.com/read/38585732/computational-deconvolution-of-cell-type-specific-gene-expression-in-copd-and-ipf-lungs-reveals-disease-severity-associations
#17
Min Hyung Ryu, Jeong H Yun, Kangjin Kim, Michele Gentili, Auyon Ghosh, Frank Sciurba, Lucas Barwick, Andrew Limper, Gerard Criner, Kevin K Brown, Robert Wise, Fernando J Martinez, Kevin R Flaherty, Michael H Cho, Peter J Castaldi, Dawn L DeMeo, Edwin K Silverman, Craig P Hersh, Jarrett D Morrow
RATIONALE: Chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) are debilitating diseases associated with divergent histopathological changes in the lungs. At present, due to cost and technical limitations, profiling cell types is not practical in large epidemiology cohorts (n>1000). Here, we used computational deconvolution to identify cell types in COPD and IPF lungs whose abundances and cell type-specific gene expression are associated with disease diagnosis and severity...
March 27, 2024: medRxiv
https://read.qxmd.com/read/38581672/patient-characteristics-diagnostic-testing-and-initial-treatment-profiles-of-patients-with-connective-tissue-disease-associated-pulmonary-arterial-hypertension-ctd-pah-using-a-japanese-claims-database
#18
JOURNAL ARTICLE
Natsuko Tokushige, Yasuhiro Hayashi, Junichi Omura, Tatsunori Jinnai, Tatsuya Atsumi
OBJECTIVES: To investigate the diagnostic and therapeutic landscape for patients with connective tissue disease (CTD) and CTD-associated pulmonary arterial hypertension (CTD-PAH) in acute-care general hospitals in Japan. METHODS: We conducted a retrospective cohort study by analysing the Medical Data Vision (MDV) database from April 2008 and September 2020. CTD patients who prescribed immunosuppressants were included in cohort 1, and CTD-PAH patients extracted from cohort 1 were included in cohort 2...
April 6, 2024: Modern Rheumatology
https://read.qxmd.com/read/38572864/two-and-3-year-outcomes-in-convalescent-individuals-with-covid-19-a-prospective-cohort-study
#19
JOURNAL ARTICLE
Huqin Yang, Lujia Guan, Tingyu Yang, Haomiao Ma, Xuefeng Liu, Xuyan Li, Jieqiong Li, Zhaohui Tong
As the long-term consequences of coronavirus disease 2019 (COVID-19) have not been defined, it is necessary to explore persistent symptoms, long-term respiratory impairment, and impact on quality of life over time in COVID-19 survivors. In this prospective cohort study, convalescent individuals diagnosed with COVID-19 were followed-up 2 and 3 years after discharge from hospital. Participants completed an in-person interview to assess persistent symptoms and underwent blood tests, pulmonary function tests, chest high-resolution computed tomography, and the 6-min walking test...
April 2024: Journal of Medical Virology
https://read.qxmd.com/read/38570751/genetic-association-between-smoking-and-dlco-in-idiopathic-pulmonary-fibrosis-patients
#20
JOURNAL ARTICLE
Ziheng Yuan, Wanyang Lei, Xiqian Xing, Xiaohua He, Xiaoxian Huang, Li Wei, Yuanyuan Lv, Shuyi Qiu, Ziyu Yuan, Jiyang Wang, Mei Yang
BACKGROUND: Observational studies have shown that smoking is related to the diffusing capacity of the lungs for carbon monoxide (DLCO) in individuals with idiopathic pulmonary fibrosis (IPF). Nevertheless, further investigation is needed to determine the causal effect between these two variables. Therefore, we conducted a study to investigate the causal relationship between smoking and DLCO in IPF patients using two-sample Mendelian randomization (MR) analysis. METHODS: Large-scale genome-wide association study (GWAS) datasets from individuals of European descent were analysed...
April 3, 2024: BMC Pulmonary Medicine
keyword
keyword
39657
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.